The Devil in the Details

The devil, as the old saying goes, is in the details. Or, in the case of the new Estonian law setting up a national genetic data bank, there is reason for concern that the devil may get involved in the actual workings of that country's Human Gene Research Act (See "Gene Pool Expeditions," page 1). The authors of the 34-section act have made a serious effort to prevent misuse of the data and to protect gene donors' rights and privacy. Participation in the project is strictly voluntary, on

Written byJaan Kangilaski
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The devil, as the old saying goes, is in the details. Or, in the case of the new Estonian law setting up a national genetic data bank, there is reason for concern that the devil may get involved in the actual workings of that country's Human Gene Research Act (See "Gene Pool Expeditions," page 1).

The authors of the 34-section act have made a serious effort to prevent misuse of the data and to protect gene donors' rights and privacy. Participation in the project is strictly voluntary, on the basis of informed consent. It will be illegal to ask anyone if he or she is participating in the free program. People won't be paid for providing a tissue sample, medical, and family history to the Estonian Gene Bank. That information is immediately given "a unique code consisting of at least 16 random characters." Genetic and medical data become and remain ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies